Ophthalmology, Cornea and External Diseases Specialist · Elmhurst, NY
NPI
1184814048
Since 2007
Specialty
Ophthalmology, Cornea and External Diseases Specialist
Code 207WX0120X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
8626 Queens Blvd
Elmhurst, NY, 11373
Phone (516) 641-7691
Groups this clinician bills Medicare through
Medicare paid, 2024
$155K
3,163 services
Medicare patients, 2024
337
Average age 71
Drug cost, 2024
$525K
3,610 prescriptions
Company payments, 2025
$698
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Neelofar Ghaznawi was code 92012 (ophthalmological e&m), 412 times for 211 patients. In total Neelofar Ghaznawi billed 3,163 services in 40 codes, and Medicare paid $155K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-10-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92012 Ophthalmological E&M | Office | 412 | 211 | $71.86 | $30K |
| 92134 Computerized Ophthalmic Imaging | Office | 411 | 294 | $32.04 | $13K |
| 92286 Standard X-ray | Office | 345 | 292 | $31.20 | $11K |
| 92025 Test - Miscellaneous | Office | 328 | 288 | $28.86 | $9,465 |
| 76514 Ultrasound - Nonspecific | Office | 322 | 272 | $9.50 | $3,060 |
| 92201 Ophthalmological E&M | Office | 227 | 211 | $20.17 | $4,578 |
| 92002 Ophthalmological E&M | Office | 184 | 184 | $65.97 | $12K |
| 92136 Ultrasound - Nonspecific | Office | 164 | 91 | $19.21 | $3,150 |
| 92250 Angiography | Office | 131 | 114 | $31.52 | $4,130 |
| 76512 Ultrasound - Nonspecific | Office | 97 | 91 | $63.06 | $6,116 |
| 68761 Eye | Office | 83 | 43 | $156.23 | $13K |
| 92020 Ophthalmological E&M | Office | 73 | 67 | $23.88 | $1,744 |
| 92133 Computerized Ophthalmic Imaging | Office | 56 | 52 | $28.33 | $1,587 |
| 66984 Cataract Surgery | Facility | 51 | 37 | $469.35 | $24K |
| 92083 Vision, Hearing, and Speech Services | Office | 34 | 28 | $52.46 | $1,784 |
By year: 2022 $127K for 2,154 services; 2023 $151K for 3,153 services; 2024 $155K for 3,163 services.
Medicare prescription drug claims, 2024
In 2024, the drug Neelofar Ghaznawi prescribed most often to Medicare patients was Azelastine Hcl, with 702 prescriptions and refills. In total Neelofar Ghaznawi wrote 3,610 Medicare prescriptions that cost $525K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Azelastine Hcl Generic | 702 | 812 | 223 | $11K |
| Prednisolone Acetate Generic | 447 | 609 | 251 | $19K |
| Latanoprost Generic | 412 | 659 | 117 | $3,379 |
| Ofloxacin Generic | 267 | 326 | 190 | $4,273 |
| Ketorolac Tromethamine Generic | 255 | 394 | 178 | $3,321 |
| Restasis Cyclosporine | 232 | 290 | 75 | $177K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 173 | 336 | 56 | $2,722 |
| Restasis Multidose Cyclosporine | 95 | 113 | 29 | $61K |
| Timolol Maleate Generic | 90 | 159 | 26 | $2,666 |
| Lumigan Bimatoprost | 85 | 139 | 25 | $37K |
| Brimonidine Tartrate Generic | 80 | 125 | 31 | $3,138 |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 75 | 84 | 69 | $3,357 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 67 | 67 | 53 | $583 |
| Cyclosporine Generic | 54 | 80 | 29 | $25K |
| Combigan Brimonidine Tartrate/Timolol | 45 | 82 | Under 11 | $19K |
Brand drugs: 1,326 claims; generic drugs: 2,284 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Neelofar Ghaznawi $698 ($698 in general payments such as food, travel and fees) from 8 companies. The largest payer was Mallinckrodt Hospital Products Inc. with $302.
| Company | Payments | Amount |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 7 | $302 |
| Bausch & Lomb Americas Inc. BLCO | 5 | $91.1 |
| Dompe US, Inc. | 3 | $71.82 |
| Amgen Inc. AMGN | 2 | $51.63 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 2 | $49.3 |
| Alcon Vision LLC ALC | 2 | $47.26 |
| Harrow Eye, LLC | 2 | $46.21 |
| Oyster Point Pharma, Inc. | 2 | $39.13 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.